Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry Developments

Top Articles
:

Russia

The Federal Antimonopoly Service's decision, to block a proposed merger between Abbott Laboratories Petrovax Pharm, while unexpected, does not signal a worsening investment climate... 2013-04-22


Ukraine

BMI View: The announcement by the health minister that compulsory health insurance is unlikely to be rolled out in the short term is disappointing but not unexpected, given the country's... 2013-04-10


Ukraine

BMI View: Although largely regressive, the impact of the government's move to limit medicine procurement to domestic production will be low, given the small scale of state drug expenditure... 2013-04-09


More ARTICLES

BMI View: With the exception of Kazakhstan, the Central Asian republics remain largely insular. The significant barriers to entry for multinational drugmakers and the level of state... 2013-04-08


Russia

BMI View: Moves by Russia's Ministry of Industry and Trade to liberalise the over-the-counter (OTC) medicine sector are coming to fruition, with the Health Ministry having the final... 2013-04-03


BMI View: Trade data from UN Comtrade highlights the challenging conditions present in 2012, as imports fell in countries affected by the eurozone decline, such as Turkey and the Czech... 2013-03-27


Ukraine

BMI View: Drugmakers in Emerging Europe must contend with import restrictions as countries including Russia and Ukraine attempt to develop their own nascent pharmaceutical sectors and... 2013-03-25


Russia

BMI View: While drug imports may have declined in 2012, we believe the innovation gap between multinational and Russian drugmakers will continue to favour the multinationals. Russia's... 2013-03-22

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries